COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 179 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $54,952,843 | -13.2% | 1,706,610 | +4.6% | 0.01% | -14.3% |
| Q1 2024 | $63,340,886 | +42.7% | 1,631,656 | +13.2% | 0.01% | +27.3% |
| Q4 2023 | $44,372,971 | +71.2% | 1,441,617 | +24.3% | 0.01% | +57.1% |
| Q3 2023 | $25,917,148 | +5.8% | 1,159,604 | +1.7% | 0.01% | +16.7% |
| Q2 2023 | $24,495,678 | -10.4% | 1,139,864 | -0.0% | 0.01% | -25.0% |
| Q1 2023 | $27,351,072 | +10.4% | 1,140,103 | +6.7% | 0.01% | +14.3% |
| Q4 2022 | $24,778,831 | +52.5% | 1,068,053 | +5.3% | 0.01% | +40.0% |
| Q3 2022 | $16,245,000 | -8.9% | 1,014,088 | +0.8% | 0.01% | 0.0% |
| Q2 2022 | $17,831,000 | -13.3% | 1,006,191 | -0.4% | 0.01% | 0.0% |
| Q1 2022 | $20,576,000 | +10.2% | 1,010,612 | +1.1% | 0.01% | 0.0% |
| Q4 2021 | $18,671,000 | -1.5% | 999,522 | +4.1% | 0.01% | 0.0% |
| Q3 2021 | $18,960,000 | -17.6% | 960,505 | -1.3% | 0.01% | -16.7% |
| Q2 2021 | $23,009,000 | +4.3% | 973,311 | +4.5% | 0.01% | 0.0% |
| Q1 2021 | $22,064,000 | +61.2% | 931,025 | +36.3% | 0.01% | +50.0% |
| Q4 2020 | $13,684,000 | +20.8% | 683,177 | +25.6% | 0.00% | 0.0% |
| Q3 2020 | $11,325,000 | -5.0% | 543,909 | -20.2% | 0.00% | 0.0% |
| Q2 2020 | $11,923,000 | +4.7% | 681,371 | -2.3% | 0.00% | -20.0% |
| Q1 2020 | $11,390,000 | +2664.6% | 697,469 | +3383.3% | 0.01% | – |
| Q4 2019 | $412,000 | -48.9% | 20,023 | -62.4% | 0.00% | – |
| Q1 2019 | $807,000 | -67.8% | 53,279 | -63.5% | 0.00% | -100.0% |
| Q4 2018 | $2,504,000 | +576.8% | 145,832 | +482.1% | 0.00% | – |
| Q3 2018 | $370,000 | -92.7% | 25,052 | -88.3% | 0.00% | -100.0% |
| Q2 2018 | $5,086,000 | +3.4% | 213,237 | +10.7% | 0.00% | 0.0% |
| Q1 2018 | $4,920,000 | +81900.0% | 192,574 | +62020.6% | 0.00% | – |
| Q2 2015 | $6,000 | – | 310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $2,364,000 | 4.71% |
| GREAT POINT PARTNERS LLC | 861,410 | $20,364,000 | 4.27% |
| Rubric Capital Management LP | 2,420,214 | $57,214,000 | 3.60% |
| Camber Capital Management LP | 2,000,000 | $47,280,000 | 1.59% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 416,244 | $9,840,000 | 1.10% |
| Eventide Asset Management | 2,629,593 | $62,164,000 | 0.84% |
| RICE HALL JAMES & ASSOCIATES, LLC | 799,298 | $18,895,000 | 0.67% |
| EMERALD ADVISERS, LLC | 741,278 | $17,524,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 790,391 | $18,685,000 | 0.61% |
| Values First Advisors, Inc. | 37,222 | $880,000 | 0.60% |